An open-label, two-cohort study to assess the effect of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Atorvastatin; Lamotrigine; Phenytoin
- Indications Alzheimer's disease; Bipolar disorders; Cardiovascular disorders; Diabetic nephropathies; Epilepsy; Hypercholesterolaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Lennox-Gastaut syndrome; Low HDL cholesterol; Partial epilepsies; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 14 Oct 2010 Actual end date (September 2008) added as reported by ClinicalTrials.gov.
- 14 Oct 2008 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov.
- 20 Mar 2008 New trial record.